These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. GRNOPC1: the world's first embryonic stem cell-derived therapy. Interview with Jane Lebkowski. Lebkowski J Regen Med; 2011 Nov; 6(6 Suppl):11-3. PubMed ID: 21999256 [TBL] [Abstract][Full Text] [Related]
10. Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365 [TBL] [Abstract][Full Text] [Related]
11. Translating stem cell research: challenges at the research frontier. Magnus D J Law Med Ethics; 2010; 38(2):267-76. PubMed ID: 20579250 [TBL] [Abstract][Full Text] [Related]
12. Possible clinical usefulness of embryonic stem cells. Aznar J; Gómez I Rev Clin Esp; 2012 Sep; 212(8):403-6. PubMed ID: 22765959 [TBL] [Abstract][Full Text] [Related]
13. Adapting Preclinical Benchmarks for First-in-Human Trials of Human Embryonic Stem Cell-Based Therapies. Barazzetti G; Hurst SA; Mauron A Stem Cells Transl Med; 2016 Aug; 5(8):1058-66. PubMed ID: 27334488 [TBL] [Abstract][Full Text] [Related]
14. Perspectives and future directions of human pluripotent stem cell-based therapies: lessons from Geron's clinical trial for spinal cord injury. Lukovic D; Stojkovic M; Moreno-Manzano V; Bhattacharya SS; Erceg S Stem Cells Dev; 2014 Jan; 23(1):1-4. PubMed ID: 23980630 [TBL] [Abstract][Full Text] [Related]
15. Embryonic stem cells. Researchers mull impact of Geron's sudden exit from field. Kaiser J Science; 2011 Nov; 334(6059):1043. PubMed ID: 22116849 [No Abstract] [Full Text] [Related]
16. Ethical issues in stem cell research and therapy. King NM; Perrin J Stem Cell Res Ther; 2014 Jul; 5(4):85. PubMed ID: 25157428 [TBL] [Abstract][Full Text] [Related]
17. Stem cells: research tools and clinical treatments. Fahey MC; Wallace EM J Paediatr Child Health; 2011 Sep; 47(9):672-5. PubMed ID: 21951457 [TBL] [Abstract][Full Text] [Related]
18. Risk of tumorigenesis in first-in-human trials of embryonic stem cell neural derivatives: Ethics in the face of long-term uncertainty. Hess PG Account Res; 2009 Jul; 16(4):175-98. PubMed ID: 20183160 [TBL] [Abstract][Full Text] [Related]
19. Resolving ethical issues in stem cell clinical trials: the example of Parkinson disease. Lo B; Parham L J Law Med Ethics; 2010; 38(2):257-66. PubMed ID: 20579249 [TBL] [Abstract][Full Text] [Related]
20. Allowing innovative stem cell-based therapies outside of clinical trials: ethical and policy challenges. Hyun I J Law Med Ethics; 2010; 38(2):277-85. PubMed ID: 20579251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]